Literature DB >> 32462665

Onset time and duration of action of rocuronium 0.6 mg/kg in patients above 80 years of age: A comparison with young adults.

Cecilie Bjerring1, Matias Vested1, Tobias Arleth1, Kirsten Eriksen1, Charlotte Albrechtsen2, Lars S Rasmussen1.   

Abstract

BACKGROUND: The number of elderly is increasing, and a large proportion of these people will require surgery and anaesthesia. However, little data exist regarding rocuronium in patients above 80 years of age. The aim of this study was to determine the onset time and duration of action for rocuronium 0.6 mg/kg in patients above 80 years compared with young adults.
METHODS: This prospective observational study included 16 young (18-40 years) and 16 elderly (>80 years) patients scheduled for total intravenous anaesthesia. Neuromuscular block following rocuronium 0.6 mg/kg was monitored with acceleromyography using train-of-four (TOF) stimulation. The primary outcome was onset time (from administration of rocuronium until TOF count = 0). Secondary outcomes were duration of action (from administration to TOF ratio > 0.9) and intubating conditions according to Intubation Difficulty Score.
RESULTS: Elderly patients, median age of 84 years, had significantly prolonged onset time compared to younger patients; median 135 s (135-158) versus 90 s (90-105), respectively, a mean difference of 82 s (40-124) and Wilcoxon Mann-Whitney odds (WMW) of 19.48 (7.48-X). Duration of action in elderly patients was significantly longer, with a median time of 81 min (71-97) versus 53 min (42-73), respectively, a mean difference of 31 min (14-48), and WMW odds of 6.35 (2.59-X). There was no significant difference in intubating conditions.
CONCLUSIONS: Patients above 80 years had significantly prolonged onset time and duration of action after rocuronium 0.6 mg/kg compared with patients aged 18 to 40 years. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  elderly; neuromuscular blocking agents; rocuronium; young adults

Year:  2020        PMID: 32462665     DOI: 10.1111/aas.13645

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

1.  Neuromuscular block in patients 80 years and older: a prospective, controlled study.

Authors:  Denis Schmartz; Raouf Sghaier; Paul Bernard; Jean François Fils; Thomas Fuchs-Buder
Journal:  BMC Anesthesiol       Date:  2021-09-13       Impact factor: 2.217

2.  Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study.

Authors:  Matias Vested; Pernille Pape; Camilla M Kristensen; Felicia Dinesen; Malene Vang; Rasmus E Christensen; Cecilie B Lindahl; Charlotte Albrechtsen; Lars S Rasmussen
Journal:  Acta Anaesthesiol Scand       Date:  2022-06-27       Impact factor: 2.274

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.